Login

Pharmaceutical giant doubles down on North Carolina investment

Genentech commits $2 billion for its East Coast manufacturing hub near Raleigh
Rendering of the Genentech facility in Holly Springs, North Carolina. (Genentech)
Rendering of the Genentech facility in Holly Springs, North Carolina. (Genentech)
CoStar Analytics
January 23, 2026 | 5:32 P.M.

Genentech announced in May that it would spend $700 million to establish its first East Coast manufacturing hub in Holly Springs, North Carolina. Less than a year later, the California-based pharmaceutical giant is set to more than double that investment.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE


  • Properties
  • Companies
    • Genentech

      Professional, Scientific, and Technical Services